Save Lives & Change The World By Growing Your Life Science, Regenerative Cell Therapy
or Biotec Business
At Cell Bridge Strategies, we understand the unique challenges and opportunities presented by working in these industries. Typical marketing strategies aren’t effective in this rapidly changing environment, which is why we teach our clients how to merge their science with business objectives, to commercialize their products and services.
Together, We Can Bridge The Gap Between Science & Business
As experts in scientific innovation, industry expansion, competition, and pharmaceutical influences, we understand the intricacies of Life Science Businesses and how to stay ahead of the curve. With direct access to Jane and the rest of her talented team at Cell Bridge Strategies, you’ll receive individualized attention and customized strategies to grow your Life Science, Regenerative Cell Therapy, or Biotec Business.
“Jane and I have known each other professionally for over 8 years. During that time, we’ve worked as colleagues in the areas of corporate strategies, new product development, and commercialization in the capacities of Executives, Consultants, and Advisors. Jane’s Life Sciences knowledge & experience, especially in the areas of Biotechnology, cell & cell-gene-based therapies is exceptional. Jane is rare among scientists in her ability to understand foundational science and trends and then intuitively and fluidly translate it into an actionable, practical business direction. Jane is exceptionally intelligent, hardworking, and diligent in her consultancy.”
Services at Cell Bridge Strategies are customized based on our client’s business needs, internal capabilities, goals, customers, and competitors. Let our team of scientists, analysts and executives support your Life Science business in:
Financial modeling based on internal capabilities and market forces
Corporate Strategies
Partner identification and negotiations
M&A considerations
Operational planning and implementation
New product development and commercialization
And more!
MEET OUR FOUNDER: JANE C. ANDREWS, MS, PH.D. & CEO
Dr. Andrews is a recognized leader in Life Sciences, Regenerative Medicine, and Cell Therapy industries. Over the years, she’s owned and built businesses, laboratories, and organizations and held numerous positions including Senior Global Healthcare & Life Science Consultant for Frost & Sullivan. Dr. Andrews has also helped clients ranging from Big Pharma, CDMOs, to academic investigators, with their business strategies, market positioning, product development, and competitive intelligence.
As a Scientist, Dr. Andrews worked for over 20 years developing cell-based assays, creating chemically defined culture systems, and studying the biochemistry and physiology of mammalian sperm, eggs, and embryos.
She’s held academic and corporate positions including:
Assistant Professorships, Senior Staff Scientist at the Audubon Center for Research of Endangered Species,
NASA Senior Scientist (Lockheed Martin Space Operations and Science Systems and Applications)
Senior Director of Mid-sized biotechnology, blood bank, and Biomanufacturing company.
Dr. Andrews also lectures frequently to professional groups, including the World Stem Cell Summit (US 2013 - 2020), Mixii Bio (Israel, 2017), and The World Advanced Therapies & Regenerative Medicine Congress & Expo in London (2019). She has earned awards for her work with NASA, as well as honorarium from NIH and The Smithsonian Institute, and has written numerous published papers and proprietary reports on her work over the years. Jane received her BS, MS, and Ph.D. from the University of Wisconsin–Madison, followed by a Postdoctoral Fellowship at the Pennsylvania State University.
In her spare time, Dr. Andrews and her husband are Ranchers in Texas. They raise Reining Horses and breed Australian Shepherds, and actively compete in National Reining Horse Association Shows.
Meet Cell Bridge Strategies Experts
Our talent pool features experienced medical professionals, scientists, legal professionals, CEO, COOs, and CFOs who provide you with the right guidance and strategies to elevate your business to the next level.
Neil Kellen, CFO and Principal Consultant
[insert bio]
[insert bio]
Preveen Ramamoorthy: Ph.D., Advisory Board Member, Cell Bridge Strategies, LLC
Dr. Ramamoorthy is a leader in Global Precision Medicine - Cell & Gene Therapy, Biologics, Biomarkers, Diagnostics and Medical Devices. He is a clinician by wiring and a biologist by training. He is a passionate, patient centric-innovator, global executive, entrepreneur, and academician with 15+ years of experience. Dr. Ramamoorthy is a leader in Global Precision Medicine - Cell & Gene Therapy, Biologics, Biomarkers, Diagnostics and Medical Devices.
Steven Schmid: Ph.D., Principal Consultant, Cell Bridge Strategies, LLC
Dr. Schmid has 30 years of experience in FDA relations, involving new drug development in Oncology and cell-based therapies. He has directed numerous drug development laboratories, a flow cytometry facility, worked extensively as a Marketing and Sale Liaison, and served as both COO and CSO for leading Biotechnology companies.
He’s written and participated in IND, NDA, and BLA submissions that were approved for cancer therapeutics. He’s conducted eCTD submissions for cancer therapeutics, managed GLP and GMP Laboratories in Cell Biology and Immunology, run discovery and barrier vivarium’s and has held a DEA license. Areas of investigation and drug development include pharmaceuticals, biosimilars, cell therapy, exosomes, and tissues. Dr. Schmid has participated in GMP audits for companies including DOW Chemical, and in CLIA Audits in the US and Europe. He received his BS and MA from Drake University, Des Moines, IA, a Ph.D. in Microbiology/V
He is a clinician by wiring and a biologist by training. He is a passionate, patient centric-innovator, global executive, entrepreneur, and academician with 15+ years of experience. His in-depth and breadth of people, product and process leadership experience spans Biologics Development (Vaccines, MAbs), Precision Medicine Diagnostics (Genomics, Proteomics, Immunoassays, Multi-Omics Biomarkers), and Medical Devices (Blood Transfusion, Immunotherapy, Stem Cell Therapy, Cell & Gene Therapy, CAR-T Cell Therapy).
His specialties include R&D/Innovation Leadership; Pre-Clinical & Clinical Development; Global Lab & Clinical Operations; Data Analytics (Bioinformatics & AI); Therapeutic Experience (Oncology, Immune Diseases, Rare Diseases, Infectious Diseases); Customer Intimacy; Rapid Ideation to Revenue Impact; Strategic Scientific & Clinical Collaboration; Market Intelligence.
He has held numerous positions including President, Clinical Diagnostics and Head of R&D for Healthtell/Icarbonx; Vice President, Global Scientific & Clinical Affairs for Terumo BCT; Head of Diagnostics & Vice President of Clinical Diagnostics, Strand Life Sciences.
Jan Rodriguez: RN, CCRA, Senior Consultant, Cell Bridge Strategies, LLC
Jan Rodriguez is a Registered Nurse, CCRA, and expert at managing and monitoring international and national Clinical Trials ranging from Phase I- IV for drugs, medical devices and biologics. Ms. Rodriguez's 20 years of experience includes clinical monitoring, project management, regulatory, contract negotiations, study start-up, SAE reporting/reconciliation, and development of study-specific tools.
Her therapeutic areas of experience include Hematology/Oncology; Analgesia; Cardiology; CNS; Diabetes; Endocrinology; Gene Therapeutics; Infectious Disease; Pediatrics; Orthopedic/Skeletal Diseases; Medical Devices.
Mike Dwyer, Advisory Board Member, Cell Bridge Strategies, LLC
Mr. Dwyer is an experienced executive with a demonstrated history of working in the biotechnology industry. His is skilled in Medical Devices, Clinical Trials, Data Management, Biotechnology, Regulatory Requirements as well as Finance. He is currently the President & CEO, Vida Medical Devices, Inc, and the Director, Vice President & Member of the Investment Committee for the San Antonio Economic Development Corporation. He has previously help positions as: President - MTD Associates, LLC; President & CEO - Azaya Therapeutics, Inc; Executive Vice President, Ilex Oncology, Senior VP Quintiles Translational; Partner - Arthur Anderson.
Rick Stockton, Principal Consultant, Cell Bridge Strategies
Rick is also Designer and Principal at J. R. Stockton Consulting, LLC. Rick’s background in process engineering, manufacturing, and device design makes him an ideal fit for Cell Bridge Strategies clients, that are undergoing facility and new product design and/or scale-up. His innate conceptual abilities allow him to visualize the process and task at hand and create the best three-dimensional solutions for buildout, equipment design and validation. He is an expert at product and system development, from a conceptual and mechanical perspective. He routinely works on process, manufacturing, product development, ideation, invention and complete product and system design at the corporate level.
His typical work is to take an existing concept or desire and compliment it with the things that will make it practical to produce, deploy and maintain a) Concepts become working prototypes ready to be validated; b) Prototypes become reliable, affordable, rapidly manufactured products; c) Design’s interface between products and those who use them; d) Design systems utilize the products, including human interfaces, machine interfaces, and facility layouts.
Court Square Group
Court Square Group (CSG) (courtsquaregroup.com) is the leading provider of an Audit Ready Compliant Cloud™ (ARCC) platform for Life Science companies. The ARCC cloud platform and out-of-the-box tools provide a validated and cost-effective way to manage all digital content (EDMS/documents, voice, data, and video) in a regulated and compliant environment. CSG also provides cloud-based backup solutions for data integrity and data protection for in-house systems. At every stage of the development and manufacturing lifecycle, Court Square’s cloud, collaboration and regulatory submission solutions reduce costs, complexity and risks associated with sharing, storing, and submitting information for regulatory requirements. With over 1,000+ submissions and twenty-five years’ experience and a 95% client retention rate, CSG has a proven track record as one of the most cost-efficient solutions in the life science market.
“I’ve served on two Cell Therapy Biomanufacturing advisory boards that Jane has created and held the stage with her at numerous conferences. Jane is an expert in the field of Regenerative Medicine and Cellular Therapies and works tirelessly to help her clients grow their businesses. I’ve enjoyed working with Jane over the years as she is thoughtful, thorough, and strategic. I’d highly recommend her and her team at Cell Bridge Strategies as a ‘go to’ for early and mid-stage business development, strategies and growth.”